Isemoto, K.; Waseda, Y.; Fujiwara, M.; Kimura, K.; Hirahara, D.; Saho, T.; Takaya, E.; Arita, Y.; Kwee, T.C.; Fukuda, S.;
et al. Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer. Diagnostics 2025, 15, 801.
https://doi.org/10.3390/diagnostics15070801
AMA Style
Isemoto K, Waseda Y, Fujiwara M, Kimura K, Hirahara D, Saho T, Takaya E, Arita Y, Kwee TC, Fukuda S,
et al. Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer. Diagnostics. 2025; 15(7):801.
https://doi.org/10.3390/diagnostics15070801
Chicago/Turabian Style
Isemoto, Kohei, Yuma Waseda, Motohiro Fujiwara, Koichiro Kimura, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Yuki Arita, Thomas C. Kwee, Shohei Fukuda,
and et al. 2025. "Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer" Diagnostics 15, no. 7: 801.
https://doi.org/10.3390/diagnostics15070801
APA Style
Isemoto, K., Waseda, Y., Fujiwara, M., Kimura, K., Hirahara, D., Saho, T., Takaya, E., Arita, Y., Kwee, T. C., Fukuda, S., Tanaka, H., Yoshida, S., & Fujii, Y.
(2025). Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer. Diagnostics, 15(7), 801.
https://doi.org/10.3390/diagnostics15070801
